VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q2 2026

Top Holdings55 positions

Checking export access…
Activity:
VUGVUG
ETF

Vanguard Morningstar Growth ETF

6.8M$584.9M4.4%$78.89+13.81%
16 qtrssince 2022-Q3
Increased
93
QQQMQQQM
ETF

Invesco Exchange Traded Fd Tr Ii Nasdaq 100 Etf

1.9M$580.6M4.3%$246.17+21.78%
4 qtrssince 2025-Q3
Decreased
0
SCHGSCHG
ETF

SCHWAB STRATEGIC TR

17.1M$577.6M4.3%$31.85+12.80%
4 qtrssince 2025-Q3
Unchanged
0
SPYGSPYG
ETF

SPDR SERIES TRUST

4.2M$501.2M3.8%$103.96+18.00%
4 qtrssince 2025-Q3
Decreased
0
IEFAIEFA
ETF

iShares Core MSCI EAFE ETF

4.2M$402.7M3.0%$85.55+12.95%
4 qtrssince 2025-Q3
Decreased
0
VGTVGT
ETF

VANGUARD WORLD FD

3.3M$397.7M3.0%$93.07+31.45%
4 qtrssince 2025-Q3
Increased
86
AGGAGG
ETF

ISHARES TR

3.9M$383.7M2.9%$93.40+2.15%
25 qtrssince 2020-Q2
Decreased
0
FELGFELG
ETF

FIDELITY COVINGTON TRUST

8.6M$377.7M2.8%$41.00+8.89%
4 qtrssince 2025-Q3
Unchanged
0
MGKMGK
ETF

VANGUARD WORLD FD

4.3M$377.6M2.8%$80.36+14.58%
4 qtrssince 2025-Q3
Increased
86
SPMOSPMO
ETF

INVESCO EXCH TRADED FD TR II

2.2M$360.3M2.7%$120.04+20.11%
4 qtrssince 2025-Q3
Decreased
0
VYMVYM
ETF

Vanguard High Dividend Yield

2.2M$345.2M2.6%$137.68+16.19%
4 qtrssince 2025-Q3
Decreased
0
SPYMSPYM
ETF

SPDR SER TR

3.9M$341.6M2.6%$77.50+17.22%
4 qtrssince 2025-Q3
Decreased
0
IEMGIEMG
ETF

iShares Core MSCI Emerging Markets ETF

4M$332.8M2.5%$64.69+20.71%
4 qtrssince 2025-Q3
Decreased
0
VEAVEA
ETF

VANGUARD FTSE DEVELOPED ETF

4.6M$328.4M2.5%$58.59+18.89%
4 qtrssince 2025-Q3
Decreased
0
VOTVOT
ETF

VANGUARD INDEX FDS

1M$319.4M2.4%$289.33+1.79%
4 qtrssince 2025-Q3
Unchanged
0
SPDWSPDW
ETF

SPDR INDEX SHS FDS

6.2M$313.1M2.3%$41.47+19.41%
4 qtrssince 2025-Q3
Decreased
0
SPHQSPHQ
ETF

INVESCO EXCHANGE TRADED FD T

3.4M$309.8M2.3%$73.09+16.13%
4 qtrssince 2025-Q3
Increased
55
IWPIWP
ETF

iShares Russell Mid-Cap Growth ETF

2.1M$308M2.3%$140.88-2.45%
4 qtrssince 2025-Q3
Unchanged
0
IMCGIMCG
ETF

ISHARES TR

3M$295.5M2.2%$82.14+15.68%
4 qtrssince 2025-Q3
Unchanged
0
RWLRWL
ETF

INVESCO EXCH TRADED FD TR II

2.2M$275.3M2.1%$109.20+23.11%
4 qtrssince 2025-Q3
Decreased
0
$13.4B
AUM
55
Positions
Q2 2026
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+41%Q1'25$877.1M+14%Q2'25$997.1M+1128%Q3'25$12.2B+1%Q4'25$12.4B-5%Q1'26$11.8B+13%Q2'26$13.4B
Activity profile
$ moved · Q2'26
New0%Increased37%Decreased63%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q0%1-4Q85%1-2Y2%2Y+13%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $13.4B across 55 positions as of Q2 2026. Top holdings: VUG (4.4%), QQQM (4.3%), SCHG (4.3%). Fund DNA: Steady Compounder. HoldingsIntel Score: 1/5.0.

Q2 2026 Summary

Increased 14, trimmed 25. Top move: VUG (INCREASED, conviction 93). Portfolio: $13.4B across 55 positions.

Top holdings by portfolio weight

Total AUM$13B
VUG4.38%
QQQM4.34%
SCHG4.32%
SPYG3.75%
IEFA3.01%
VGT2.98%
AGG2.87%
FELG2.83%
MGK2.83%
SPMO2.70%
Other2.58%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L83
Conviction49
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVanguard Morningstar Growth ETF
Q3 2025 → Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAMERICAN CENTY ETF TR
Q4 2025 → Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVanguard FTSE Emerging Markets
Q1 2026 → Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used